Medicare billing address
CMS Medicare provider billing file
1011 Reed AveSuite 300
Wyomissing, PA 19610
CMS public data · NPI 1154393684
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Daniel Blecker, M.D.
Specialty
Credential
M.D.
NPI
1154393684
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Daniel Blecker, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1011 Reed AveCMS Doctors & Clinicians file
1011 Reed AveIn the 2024 CMS provider billing file, this NPI had 624 Medicare beneficiaries and 5,546 total services. The average beneficiary age was 74, and the average HCC risk score was 1.4.
Total Medicare allowed amount
$228,577.85
Total Medicare payment amount
$181,439.35
Medicare beneficiaries
624
Total services
5,546
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
32%
CMS beneficiary-panel share
Anxiety
32%
CMS beneficiary-panel share
Ischemic heart disease
31%
CMS beneficiary-panel share
Chronic kidney disease
29%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 164 | $242.36 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 133 | $120.64 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 101 | $92.20 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 92 | $85.84 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 48 | $125.99 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 48 | $47.23 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 44 | $175.89 |
| Biopsy of large bowel using a flexible endoscope | 32 | $114.61 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 30 | $159.84 |
| Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more | 28 | $53.30 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1154393684. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Pantoprazole Sodium | Pantoprazole Sodium | 237 | 647.5 | $3,739.09 |
| 2 | Omeprazole | Omeprazole | 220 | 602 | $2,868.91 |
| 3 | Famotidine | Famotidine | 108 | 286 | $1,811.93 |
| 4 | Linzess | Linaclotide | 72 | 106 | $55,195.62 |
| 5 | Colestipol Hcl | Colestipol Hcl | 54 | 130 | $9,188.93 |
| 6 | Esomeprazole Magnesium | Esomeprazole Magnesium | 51 | 141 | $1,987.51 |
| 7 | Sucralfate | Sucralfate | 33 | 49 | $7,309.93 |
| 8 | Cholestyramine | Cholestyramine (With Sugar) | 29 | 53.8 | $2,297.02 |
| 9 | Dicyclomine Hcl | Dicyclomine Hcl | 21 | 61 | $832.43 |
| 10 | Peg 3350-Electrolyte | Sodium Chloride/Nahco3/Kcl/Peg | 20 | 20 | $413.90 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
New York Medical College
Graduation year
1993
Group/practice field
Regional Gastroenterology Associates Of Lancaster, Ltd.
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.